[1]
D. Hyams, J. Byun, B. Martin, C. Bailey, T. Stumpf, and V. Petkov, “Combining the 31-gene expression profile test for cutaneous melanoma with the American Joint Committee on Cancer staging identifies the highest-risk patients with stage I-II disease”, J of Skin, vol. 7, no. 4, p. s223, Jul. 2023.